Krystal Biotech
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $91,139 | $83,841 | $70,284 | $45,250 |
Gross Profit | 86,190 | 77,157 | 62,289 | 42,831 |
EBITDA | 42,934 | 31,257 | 18,031 | 2,541 |
EBIT | 41,379 | 29,728 | 16,045 | 932 |
Net Income | 45,479 | 27,180 | 15,568 | 932 |
Net Change In Cash | 91,139 | 83,841 | 70,284 | 45,250 |
Free Cash Flow | 52,042 | 57,811 | -5,299 | 14,628 |
Cash | 344,865 | 373,966 | 345,786 | 359,006 |
Basic Shares | 29,883 | 29,902 | 29,637 | 29,291 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $290,515 | $50,699 | $0 | $0 |
Gross Profit | 270,454 | 47,605 | -4,054 | -2,769 |
EBITDA | 109,909 | 17,904 | -145,196 | -65,309 |
EBIT | 103,195 | 12,897 | -149,250 | -68,078 |
Net Income | 89,159 | 10,932 | -139,975 | -69,570 |
Net Change In Cash | 290,515 | 50,699 | 0 | 0 |
Cost of Revenue | 72,977 | |||
Free Cash Flow | 119,182 | -100,603 | -153,548 | -116,274 |
Cash | 344,865 | 358,328 | 161,900 | 341,246 |
Basic Shares | 29,740 | 27,751 | 25,491 | 22,196 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $1.53 |
2024-09-30 | $0.91 |
2024-06-30 | $0.53 |
2024-03-31 | $0.03 |
